Clinical trial
Sentinel - Triaging Acute Breathlessness Using Multi-Modal Biomarkers
NCT05304494 is registered in ClinicalTrials.gov with Sanome as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sentinel - Triaging Acute Breathlessness Using Multi-Modal Biomarkers
- Lead sponsor
- Sanome
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- March 31, 2022
- Completion date
- March 31, 2024
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.